Browsing Tag
Enspryng
1 post
Roche gets January FDA date for Enspryng after cutting MOGAD relapse risk 68%
Roche has secured FDA Priority Review for Enspryng in MOGAD after Phase 3 data showed a 68% reduction in relapse risk, with a U.S. decision due by January 10, 2027.